Market Cap 1.68B
Revenue (ttm) 0.00
Net Income (ttm) -109.36M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.06
Volume 369,100
Avg Vol 401,558
Day's Range N/A - N/A
Shares Out 34.57M
Stochastic %K 8%
Beta 0.77
Analysts Strong Sell
Price Target $99.89

Latest News on IRON

Disc Medicine to Participate in Upcoming Investor Conferences

Feb 26, 2025, 8:00 AM EST - 5 weeks ago

Disc Medicine to Participate in Upcoming Investor Conferences


Disc Medicine Announces Underwritten Offering of Common Stock

Jun 14, 2024, 8:03 AM EDT - 10 months ago

Disc Medicine Announces Underwritten Offering of Common Stock


FDA Grants Orphan Drug Designation to 9MW3011

Feb 20, 2024, 9:00 AM EST - 1 year ago

FDA Grants Orphan Drug Designation to 9MW3011


Disc Medicine: Rare Disease Biotech With Enormous Potential

Oct 25, 2023, 8:42 AM EDT - 1 year ago

Disc Medicine: Rare Disease Biotech With Enormous Potential


FDA Grants Fast Track Designation to 9MW3011

Sep 21, 2023, 8:00 PM EDT - 1 year ago

FDA Grants Fast Track Designation to 9MW3011


Disc Medicine: Rare Disease Developer Derisking Itself

Aug 22, 2023, 5:43 AM EDT - 1 year ago

Disc Medicine: Rare Disease Developer Derisking Itself